Active, Not Recruiting
Long-Term Real-World Evidence Study to Evaluate Effectiveness, Persistence, Adherence, Safety and Tolerability of Long-acting Cabotegravir Plus Rilpivirine.
NCT07703748
- Conditions
- Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Chemically-Induced Disorders, +21 more
- Locations
-
- Hospital Universitario de Burgos Burgos, Spain